Teva Pharmaceutical Finance Netherlands III B.V. Teva Pharmaceutical Finance Netherlands II B.V.
Teva Pharmaceutical Industries LTD | PDF | Generic Drug | American Depositary Receipt
NEUBERGER BERMAN INVESTMENT FUNDS PLC INFORME SEMESTRAL 2021
Teva Pharmaceutical Industries Ltd SEC Registration
PFA Pension, erhvervsobligationer
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement | Business Wire
A190FK | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 4,500 % bis 01.03.2025 | finanzen.net
A1VQDB | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,625 % bis 15.10.2028 | finanzen.net
Teva Pharmaceutical Industries Pharmaceutical industry Teva Pharmaceuticals USA, Inc. Teva Canada Teva Pharmaceutical Finance Netherlands III B.V., text, logo png | PNGEgg
Pourquoi l'obligation Teva Pharmaceutical 3,15% 2026 bondit sur le marché secondaire | Investing.com
The Complexities of ESG Bonds | ESG Investing
Most Active Foreign Bonds 12.05.2021 – Deutsche Telekom, Teva Pharma, Verizon, Citigroup, AMP Group, Credito Real SAB, EDF – Financial Markets Blog
Fourth Quarter 2019 Results
A1ZZHS | Teva Pharmaceutical Finance Netherlands II BV-Anleihe: 1,250 % bis 31.03.2023 | finanzen.net
EDM-Ahorro R FI
XS2406607171 Institutional Ownership and Shareholders - Teva Pharmaceutical Finance Netherlands II BV
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Teva Pharmaceutical Finance Netherlands II B.V. (Director) - Curaçao
Condensed Interim Unaudited Financial Statements for the six month period ended 31 May 2021
printmgr file
